About Patrick Griss
Patrick Griss is a venture builder and strategic advisor with an international track record in financing, strategy, and commercialisation across the innovation value chain. As co-founder and CEO of Zühlke Ventures, he has spent more than a decade investing in and accelerating pioneering HealthTech companies focused on prevention, early diagnosis, and patient empowerment. His portfolio includes breakthrough ventures such as Lunaphore, Bottneuro, Flow Neurosciences, and Noctrix.
With board and advisory roles across Europe and the US, Patrick supports leadership teams to transition legacy organisations into digital-first enterprisres and to bring preventive health innovations to market. His expertise lies in bridging science-based R&D with commercially scalable business models, ensuring that promising technologies in neuro-health, MedTech, and digital health reach patients faster and more effectively. Through his work, he is driving the shift from treatment-centric systems to prevention as the new paradigm in future healthcare.





